FETAL DOPPLER AND BEHAVIORAL-RESPONSES DURING HYPOGLYCEMIA-INDUCED WITH THE INSULIN CLAMP TECHNIQUE IN PREGNANT DIABETIC WOMEN

Citation
Ea. Reece et al., FETAL DOPPLER AND BEHAVIORAL-RESPONSES DURING HYPOGLYCEMIA-INDUCED WITH THE INSULIN CLAMP TECHNIQUE IN PREGNANT DIABETIC WOMEN, American journal of obstetrics and gynecology, 172(1), 1995, pp. 151-155
Citations number
18
Categorie Soggetti
Obsetric & Gynecology
ISSN journal
00029378
Volume
172
Issue
1
Year of publication
1995
Part
1
Pages
151 - 155
Database
ISI
SICI code
0002-9378(1995)172:1<151:FDABDH>2.0.ZU;2-S
Abstract
OBJECTIVE: This study was undertaken to assess human fetal behavior an d fetal blood flow after insulin-induced symptomatic maternal hypoglyc emia of sufficient magnitude to elicit counterregulatory hormones and a symptomatic response. STUDY DESIGN: Plasma glucose was lowered from approximately 95 mg/dl to 45 mg/dl in decrements of 10 mg/dl every 40 minutes with the insulin clamp technique. In 10 insulin-dependent diab etic women in the third trimester, the fetus was studied by monitoring fetal heart rate and recording fetal body and breathing movements and by performing Doppler waveform analysis with real-time ultrasonograph y. Maternal levels of glucagon, cortisol, epinephrine, and growth horm one were measured at each plasma glucose level. RESULTS: The mean numb er of fetal limb and body movements at the start of the study was 25 /- 16 per 15 minutes, which increased to a mean of 38 +/- 28 at a gluc ose level of 60 mg/dl and then declined to a mean of 23 +/- 10 at a gl ucose level of approximately 45 mg/dl. These changes, however, did not achieve statistical significance. In addition, no significant reducti ons in fetal breathing movements or heart rate were observed, although maternal epinephrine and growth hormone levels were significantly (p < 0.001) increased. No consistent changes in Doppler velocity waveform s were observed. CONCLUSION: These data suggest that fetal well-being remains unaltered in spite of moderate maternal hypoglycemia in diabet ic women.